Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

Translation, Translation, Translation

Circulation Research in Cardiology’s New Golden Age

Eduardo Marbán
Download PDF
https://doi.org/10.1161/01.RES.0000153668.49152.b4
Circulation Research. 2005;96:4-5
Originally published January 6, 2005
Eduardo Marbán
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics

Jump to

  • Article
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading
  • hemodynamics
  • diagnostics
  • interventional cardiology
  • translational research

Three factors dominate the calculation of real estate value: location, location, and location. As I enter the second half of my editorship of Circulation Research, my reflections pinpoint translation, translation, and translation as the three critical factors dominating the future of our journal. This reflection has its roots in personal ruminations about the field of clinical cardiology and how it has evolved and is evolving today.

Cardiology now finds itself in a defining epochal transition. We are on the threshold of a new Golden Age. Two Golden Ages have preceded that which we are just entering (see Table). In the 1970s and earlier, we experienced the Classical Age. This era was, necessarily, largely descriptive and observational; diseases were classified and codified, taking advantage of newly elucidated principles of fundamental hemodynamics and the development of key diagnostics in the catheterization laboratory, electrocardiography, and echocardiography. Even in this early era, however, Cardiology stood out among nonsurgical subspecialties in that our discipline actually intervened to reverse disease. What better testament can there be to Cardiology’s progressive ethos than the creation of coronary care units (CCUs)? Such units were conceived so that rhythm disturbances could be quickly recognized and treated by cardiopulmonary resuscitation, external defibrillation, or pacemakers. Such therapies, which revolutionized the practice of medicine, were hardly descriptive or observational. But the practice of cardiology relied on basic science only insofar as basic physical principles of pressure, flow, and electricity were concerned; biology was a curiosity, lamentably peripheral to the daily practice of medicine.

View this table:
  • View inline
  • View popup
Table 1.

Three Golden Ages of Cardiology

The 1980s and 1990s ushered in the second Golden Age of Cardiology: the Interventional Age. Cardiologists pioneered active methods to correct plumbing disorders (angioplasty and stents), whereas cardiac electrophysiologists developed implantable cardioverter-defibrillators and ablation. Suddenly, Cardiology was transformed from a subspecialty with a wait-and-see attitude to one in which a number of anatomical disorders could be corrected percutaneously. Still, the practice of cardiology remained rooted in principles no more biological than those required to fix an automobile. The field of thrombolysis was a prominent exception, as it required the recognition of the existence of biological fibrinolytic agents. Nevertheless, the progress of Cardiology still hinged only marginally on prior basic science work. Meanwhile, those of us working in basic science saw little evidence that our efforts would ever make much of a difference in the practice of clinical cardiology.

All this has changed with the emergence of a new Golden Age: the Translational Era. In this era, fundamental biological principles are harnessed and translated into changes in the practice of medicine. The first breezes heralding the onset of this age were the development of coated stents to inhibit coronary restenosis and the creation of abciximab, a monoclonal antibody fragment targeting the GpIIIb/IIa receptor. Neither would have been possible without sophisticated understanding of the underlying biology (for coated stents, that of vascular cell proliferation; for abciximab, that of platelet aggregation). The first breezes have recently turned into raging gales. The stem cell field is illustrative of just how fundamental, rapid, and revolutionary translation has become. Whatever we think of the controversy regarding the use of bone marrow stem cells for regenerative therapy,1 its impact on clinical practice is undeniable.2 Meanwhile, the recognition that the heart is not static but rather sustains turnover and self-repair has opened up dramatic new possibilities for autologous therapeutics using resident cardiac stem cells.3–8 Soon, we may be able to harvest stem cells from a patient’s own heart, expand them in vitro and then transplant the cells back into the same patient’s heart. This is a dizzying prospect given that we did not even recognize the existence of resident cardiac stem cells two years ago! Consider the transforming potential of other new technologies: gene therapy, genomics, proteomics, nanodevices, and hybrid therapies. The prospects are sufficiently heady to embolden us “basic scientists” who publish in Circulation Research to believe that we may, soon, make a real impact on clinical cardiology.

References

  1. ↵
    Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, Nurzynska D, Kasahara H, Zias E, Bonafé M, Nadal-Ginard B, Torella D, Nascimbene A, Quaini F, Urbanek K, Leri A, Anversa P. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. 2005; 96: 127–137.
  2. ↵
    Limbourg FP, Drexler H. Bone marrow stem cells for myocardial infarction: effector or mediator? Circ Res. 2005; 96: 6–8.
    OpenUrlFREE Full Text
  3. ↵
    Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114: 763–776.
    OpenUrlCrossRefPubMed
  4. ↵
    Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003; 100: 12313–12318.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Torella D, Rota M, Nurzynska D, Musso E, Monsen A, Shiraishi I, Zias E, Walsh K, Rosenzweig A, Sussman MA, Urbanek K, Nadal-Ginard B, Kajstura J, Anversa P, Leri A. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res. 2004; 94: 514–524.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, Goetsch SC, Gallardo TD, Garry DJ. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol. 2004; 265: 262–275.
    OpenUrlCrossRefPubMed
  7. ↵
    Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, Salio M, Battaglia M, Latronico MV, Coletta M, Vivarelli E, Frati L, Cossu G, Giacomello A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004; 95: 911–921.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Garry DJ, Martin CM. Cardiac regeneration: self-service at the pump. Circ Res. 2004; 95: 852–854.
    OpenUrlFREE Full Text
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
January 7/12, 2005, Volume 96, Issue 1
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • References
  • Figures & Tables
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Translation, Translation, Translation
    Eduardo Marbán
    Circulation Research. 2005;96:4-5, originally published January 6, 2005
    https://doi.org/10.1161/01.RES.0000153668.49152.b4

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Translation, Translation, Translation
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    Translation, Translation, Translation
    Eduardo Marbán
    Circulation Research. 2005;96:4-5, originally published January 6, 2005
    https://doi.org/10.1161/01.RES.0000153668.49152.b4
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured